Diagram of hemolytic disease of the new born
Here is a diagram illustrating the pathophysiology of Hemolytic Disease of the Newborn (HDN):
+---------------+
| Mother's |
| Blood Type |
+---------------+
|
|
v
+---------------+
| Fetal Blood |
| Type (Rh-) |
+---------------+
|
|
v
+---------------+
| Maternal |
| Immune Response|
| (Anti-Rh IgG) |
+---------------+
|
|
v
+---------------+
| Fetal Blood |
| Destruction |
| of Rh+ RBCs |
+---------------+
|
|
v
+---------------+
| Anemia in |
| Fetus |
+---------------+
|
|
v
+---------------+
| Jaundice in |
| Newborn |
+---------------+
|
|
v
+---------------+
| Exchange |
| Transfusion |
| (Phototherapy) |
+---------------+
|
|
v
+---------------+
| Recovery |
| (Most cases) |
+---------------+
Here's a brief explanation of each step:
- Mother's blood type: The mother has a blood type that is Rh-negative (Rh-).
- Fetal blood type: The fetus has a blood type that is Rh-positive (Rh+).
- Maternal immune response: When the mother's immune system detects the Rh+ blood cells from the fetus, it produces antibodies against them, specifically Anti-Rh IgG.
- Fetal blood destruction: The Anti-Rh IgG antibodies cross the placenta and bind to the Rh+ RBCs in the fetal circulation, leading to their destruction.
- Anemia in fetus: The destruction of Rh+ RBCs leads to anemia in the fetus.
- Jaundice in newborn: After birth, the anemic newborn may develop jaundice due to the breakdown of RBCs and the accumulation of bilirubin in the blood.
- Exchange transfusion: In severe cases, exchange transfusion may be necessary to remove the damaged RBCs and replace them with Rh-negative RBCs.
- Recovery: Most cases of HDN can be managed with phototherapy, which helps to break down bilirubin and reduce the risk of kernicterus (a condition that can cause brain damage).
Note: This diagram is a simplified representation of the pathophysiology of HDN. In reality, the process is more complex and may involve multiple factors, such as the amount of Anti-Rh IgG antibodies produced by the mother, the severity of anemia in the fetus, and the effectiveness of treatment.